Publication:
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine

Issued Date

2009-01-01

Resource Type

Article

ISSN

15320987
08913668

DOI

10.1097/INF.0b013e3181906351

Other identifier(s)

2-s2.0-65649111203

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Pediatric Infectious Disease Journal. Vol.28, No.4 (2009), 335-337

Suggested Citation

Krisana Pengsaa, Kriengsak Limkittikul, Arunee Sabchareon, Churdchoo Ariyasriwatana, Pornthep Chanthavanich, Phanosri Attanath, Claudius Malerczyk A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine. Pediatric Infectious Disease Journal. Vol.28, No.4 (2009), 335-337. doi:10.1097/INF.0b013e3181906351 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/28271

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine

Author(s)

Krisana Pengsaa
 Kriengsak Limkittikul
 Arunee Sabchareon
 Churdchoo Ariyasriwatana
 Pornthep Chanthavanich
 Phanosri Attanath
 Claudius Malerczyk

Other Contributor(s)

Mahidol University
 Queen Sirikit National Institute of Child Health
 Novartis Vaccines and Diagnostics

Abstract

After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 years postvaccination. The inclusion of rabies vaccine in the expanded program on immunization should be considered in rabies endemic countries. Copyright © 2009 by Lippincott Williams & Wilkins.

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/28271

Collections

Scopus 2006-2010